# A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers

> **NCT06481215** · PHASE1 · COMPLETED · sponsor: **AO GENERIUM** · enrollment: 122 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** GNR-068
- **BIOLOGICAL:** Stelara®

## Key facts

- **NCT ID:** NCT06481215
- **Lead sponsor:** AO GENERIUM
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-11
- **Primary completion:** 2022-09-04
- **Final completion:** 2022-12-20
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481215, "A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06481215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*